The Relationship between Medication Adherence and The Quality of Life of Tuberculosis Patients at the Health Center in Lamongan Regency
Hubungan Kepatuhan Minum Obat dengan Kualitas Hidup Pasien Tuberkulosis di Puskesmas Kabupaten Lamongan
Keywords:
Tuberculosis, Adherence, Quality of life
Abstract
Tuberculosis (TBC) is one of the deadliest infectious diseases in the world. Adherence to TB therapy is critical in achieving successful treatment outcomes, controlling transmission, and preventing the development of TB drug resistance. Compliance with taking antituberculosis drugs is closely related to the patient's quality of life, but the number of cases of recurrence should be a source of thought whether the patient's adherence to taking the drug will have a significant impact on the patient's quality of life. This study aims to analyze the relationship between medication adherence and the quality of life of tuberculosis patients in Lamongan. The research design is a descriptive collaborative with a cross-sectional approach. Sampling by purposive sampling with a total sample of 60 respondents. Compliance with taking medication was obtained through the MARS-5 questionnaire and quality of life using the SGRQ questionnaire. The data obtained were then analyzed with the Chi-Square test. The results showed that 70.0% of respondents had high medication adherence, and 60.0% experienced a good quality of life category. The results of the Chi-Square test showed that there was a relationship between medication adherence and the quality of life of tuberculosis patients at the Lamongan District Health Center. The more obedient the patient is in taking the drug, the better the quality of life.References
[1] World Health Organization, Global Tuberculosis Report 2022, vol. 4, no. 1. 2022.
[2] Kemenkes RI., Profil Kesehatan Indo-nesia. 2022.
[3] 2020 Dinkes Lamongan, “Profil Kesehatan Kabupaten Lamongan,” Pap. Knowl. . Towar. a Media Hist. Doc., p. 13, 2020.
[4] Dinas Kesehatan Lamongan, Profil Kesehatan Lamongan 2021. Lamongan, 2021.
[5] A. D. S. Juli Andri, Henni Febriawati, Yusuf Randi, Harsismanto, “Penatalaksanaan Pengobatan TBC Paru,” Kesmas Ascepius, vol. 21, no. 1, pp. 1–17, 2020, doi: https://doi.org/10.31539/jka.v2i2.1396.
[6] Stang, M. Rachmat, S. Marwang, and Mustamin, “Collaborative Model of Family and Health Workers Support to Improve the Success of Tuberculosis Treatment: A Qualitative Study,” Rev. Int. Geogr. Educ. Online, vol. 11, no. 5, pp. 2657–2662, 2021, doi: 10.48047/rigeo.11.05.162.
[7] World Health Organization, Administration of antituberculous drugs to subjects with basic diseases. 2. Clinical studies of INH and RFP therapy on tuberculous patients with liver diseases, vol. 62, no. 12. 2017.
[8] et al Bea Sungho, Hyesung Lee, “Aderence and Associated Factors of Treatment Regimen in Drug-Suspectible Tuberculosis Patient,” Front. Pharmacol., vol. 12, pp. 1–9, 2021, doi: 10.3389/fphar.2021.625078.
[9] A. Abubakar, O. A. Blandina, and R. Cabu, “Kepatuhan Pasien Dalam Pengobatan Tuberculosis ( TBC ) Di Puskesmas Kota Maba , Halmahera Timur The level of Tuberculosis patient treatment adherence at the Puskesmas Kota Maba , vol. 2, no. 1, pp. 27–34, 2022.
[10] Kemenkes RI, Profil Kesehatan Indonesia Tahun 2018 Ministry of Health Indonesia. 2018.
[11] C. R. Azalla, Maidar, and N. Ismail, “Analisis Kualitas Hidup Penderita TBC Paru terhadap Kepatuhan Pengobatan TBC di Wilayah Kabupaten Pidie Jaya Tahun 2020,” J. Aceh Med., vol. 4, no. 2, pp. 122–136, 2020.
[12] M. Suriya, “Faktor-Faktor Yang Berhubungan Dengan Kualitas Hidup Pasien TBC Paru Di Rumah Sakit Khusus Paru Lubuk Alung Sumatera Barat,” J. Keperawatan Abdurrab, vol. 2, no. 1, pp. 29–38, Jul. 2018, doi: 10.36341/jka.v2i1.476.
[13] M. Atif et al., “Impact of tuberculosis treatment on health-related quality of life of pulmonary tuberculosis patients: a follow-up study,” Health Qual. Life Outcomes, vol. 12, no. 1, p. 19, 2014, doi: 10.1186/1477-7525-12-19.
[14] S. Sagita, “Hubungan Tingkat Depresi Terhadap Kualitas Hidup Kota Kupang,” vol. 16, pp. 79–86, 2019, doi: 10.35508/cmj.v7i1.1493.
[15] J. E. Dian Purnama Sari, Darwin Karim, “Hubungan Kepatuhan Minum Obat Dengan Kualitas Hidup Penderita TBC Mdr Di Poli TBC Mdr Rsud Arifin Ahmad Pekanbaru,” J. Online Mhs., vol. 5, pp. 2–3, 2016.
[16] S. Andayani, “Prediksi Kejadian Penyakit TBC Paru Berdasarkan Jenis Kelamin,” J. Keperawatan Muhammadiyah Bengkulu, vol. 8, no. 2, pp. 135–140, 2020, doi: 10.36085/jkmu.v8i2.1063.
[17] N. Aja, R. Ramli, and H. Rahman, “Penularan TBC Paru dalam Anggota Keluarga di Wilayah Kerja Puskesmas Siko Kota Ternate,” Penularan TBC Paru dalam Anggota Kel. di Wil. Kerja Puskesmas Siko Kota Ternate, vol. 18, no. 1, pp. 78–87, 2022.
[18] H. A. Susanto, A. Sakka, and L. Tina, “Prediksi Kejadian Penyakit TBC Paru Bta Positif Di Kota Kendari Tahun 2016-2020 Hermawan,” J. Komunitas Kesehat. Masy., vol. 1, no. 1, pp. 1–14, 2020.
[19] S. Muflihatin, Milkhatun, and Hardianti, “Hubungan Kepatuhan Minum Obat dengan Kualitas Hidup Pasien TBC di Wilayah Kerja Puskesmas Segiri Samarinda Correlation,” J. Ilmu Kesehat., vol. 6, no. 2, 2018.
[20] R. D. Sarmen, S. H. FD, and Suyanto, “Gambaran Pengetahuan dan Sikap Pasien TBC Paru terhadap Upaya Pengendalian TBC di Puskesmas Sidomulyo Kota Pekanbaru,” Jom FK, vol. 4, no. 1, pp. 1–13, 2017.
[21] A. Novita Sari, “Tingkat Kepuasan Pasien Terhadap Pelayanan Kesehatan Di Praktik Mandiri Bidan Dyah Gonilan Sukoharjo,” Avicenna J. Heal. Res., vol. 4, no. 2, pp. 1–12, 2021, doi: 10.36419/avicenna.v4i2.525.
[22] I. G. M. S. Edi, “Faktor-Faktor Yang Mempengaruhi Kepatuhan Pasien Pada Pengobatan,” J. Ilm. Medicam., vol. 1, no. 1, pp. 1–8, Apr. 2020, doi: 10.36733/medicamento.v1i1.719.
[23] M. Meyrisca and R. Susanti, “Hubungan Kepatuhan Penggunaan Obat Anti TBC Dengan Keberhasilan Pengobatan Pasien TBC Di Puskesmas Sungai Betung Bengkayang,” Lumbung Farm. J. Ilmu Kefarmasian, vol. 3, no. 2, pp. 277–282, 2022.
[24] A. Amalia, H. D. Arini, S. Tinggi, F. Mahaganesha, and K. Denpasar, “Analisis Hubungan Tingkat Kepatuhan Minum Obat AntiTBC Terhadap Kualitas Hidup Pasien TBC Paru Analysis Of The Relationship Of Compliance Rate Of Antituberculosis Drug On The Quality Of Life Of Lung Tuberculosis,” vol. 1, no. 2, pp. 67–74, 2022.
[25] D. R. P. Papeo, M. Immaculata, and I. Rukmawati, “Hubungan Antara Kepatuhan Minum Obat (MMAS-8) Dan Kualitas Hidup (WHOQOL-BREF) Penderita TBC Di Puskesmas Di Kota Bandung,” Indones. J. Pharm. Educ., vol. 1, no. 2, pp. 86–97, 2021, doi: 10.37311/ijpe.v1i2.11143.
[26] A. Widiyanto, “Hubungan Kepatuhan Minum Obat Dengan Kesembuhan Pasien TBC Paru BTA Positif Di Puskesmas Delanggu Kabupaten Klaten,” Interes. J. Ilmu Kesehat., vol. 6, no. 1, pp. 7–12, 2017, doi: 10.37341/interest.v6i1.71.
[2] Kemenkes RI., Profil Kesehatan Indo-nesia. 2022.
[3] 2020 Dinkes Lamongan, “Profil Kesehatan Kabupaten Lamongan,” Pap. Knowl. . Towar. a Media Hist. Doc., p. 13, 2020.
[4] Dinas Kesehatan Lamongan, Profil Kesehatan Lamongan 2021. Lamongan, 2021.
[5] A. D. S. Juli Andri, Henni Febriawati, Yusuf Randi, Harsismanto, “Penatalaksanaan Pengobatan TBC Paru,” Kesmas Ascepius, vol. 21, no. 1, pp. 1–17, 2020, doi: https://doi.org/10.31539/jka.v2i2.1396.
[6] Stang, M. Rachmat, S. Marwang, and Mustamin, “Collaborative Model of Family and Health Workers Support to Improve the Success of Tuberculosis Treatment: A Qualitative Study,” Rev. Int. Geogr. Educ. Online, vol. 11, no. 5, pp. 2657–2662, 2021, doi: 10.48047/rigeo.11.05.162.
[7] World Health Organization, Administration of antituberculous drugs to subjects with basic diseases. 2. Clinical studies of INH and RFP therapy on tuberculous patients with liver diseases, vol. 62, no. 12. 2017.
[8] et al Bea Sungho, Hyesung Lee, “Aderence and Associated Factors of Treatment Regimen in Drug-Suspectible Tuberculosis Patient,” Front. Pharmacol., vol. 12, pp. 1–9, 2021, doi: 10.3389/fphar.2021.625078.
[9] A. Abubakar, O. A. Blandina, and R. Cabu, “Kepatuhan Pasien Dalam Pengobatan Tuberculosis ( TBC ) Di Puskesmas Kota Maba , Halmahera Timur The level of Tuberculosis patient treatment adherence at the Puskesmas Kota Maba , vol. 2, no. 1, pp. 27–34, 2022.
[10] Kemenkes RI, Profil Kesehatan Indonesia Tahun 2018 Ministry of Health Indonesia. 2018.
[11] C. R. Azalla, Maidar, and N. Ismail, “Analisis Kualitas Hidup Penderita TBC Paru terhadap Kepatuhan Pengobatan TBC di Wilayah Kabupaten Pidie Jaya Tahun 2020,” J. Aceh Med., vol. 4, no. 2, pp. 122–136, 2020.
[12] M. Suriya, “Faktor-Faktor Yang Berhubungan Dengan Kualitas Hidup Pasien TBC Paru Di Rumah Sakit Khusus Paru Lubuk Alung Sumatera Barat,” J. Keperawatan Abdurrab, vol. 2, no. 1, pp. 29–38, Jul. 2018, doi: 10.36341/jka.v2i1.476.
[13] M. Atif et al., “Impact of tuberculosis treatment on health-related quality of life of pulmonary tuberculosis patients: a follow-up study,” Health Qual. Life Outcomes, vol. 12, no. 1, p. 19, 2014, doi: 10.1186/1477-7525-12-19.
[14] S. Sagita, “Hubungan Tingkat Depresi Terhadap Kualitas Hidup Kota Kupang,” vol. 16, pp. 79–86, 2019, doi: 10.35508/cmj.v7i1.1493.
[15] J. E. Dian Purnama Sari, Darwin Karim, “Hubungan Kepatuhan Minum Obat Dengan Kualitas Hidup Penderita TBC Mdr Di Poli TBC Mdr Rsud Arifin Ahmad Pekanbaru,” J. Online Mhs., vol. 5, pp. 2–3, 2016.
[16] S. Andayani, “Prediksi Kejadian Penyakit TBC Paru Berdasarkan Jenis Kelamin,” J. Keperawatan Muhammadiyah Bengkulu, vol. 8, no. 2, pp. 135–140, 2020, doi: 10.36085/jkmu.v8i2.1063.
[17] N. Aja, R. Ramli, and H. Rahman, “Penularan TBC Paru dalam Anggota Keluarga di Wilayah Kerja Puskesmas Siko Kota Ternate,” Penularan TBC Paru dalam Anggota Kel. di Wil. Kerja Puskesmas Siko Kota Ternate, vol. 18, no. 1, pp. 78–87, 2022.
[18] H. A. Susanto, A. Sakka, and L. Tina, “Prediksi Kejadian Penyakit TBC Paru Bta Positif Di Kota Kendari Tahun 2016-2020 Hermawan,” J. Komunitas Kesehat. Masy., vol. 1, no. 1, pp. 1–14, 2020.
[19] S. Muflihatin, Milkhatun, and Hardianti, “Hubungan Kepatuhan Minum Obat dengan Kualitas Hidup Pasien TBC di Wilayah Kerja Puskesmas Segiri Samarinda Correlation,” J. Ilmu Kesehat., vol. 6, no. 2, 2018.
[20] R. D. Sarmen, S. H. FD, and Suyanto, “Gambaran Pengetahuan dan Sikap Pasien TBC Paru terhadap Upaya Pengendalian TBC di Puskesmas Sidomulyo Kota Pekanbaru,” Jom FK, vol. 4, no. 1, pp. 1–13, 2017.
[21] A. Novita Sari, “Tingkat Kepuasan Pasien Terhadap Pelayanan Kesehatan Di Praktik Mandiri Bidan Dyah Gonilan Sukoharjo,” Avicenna J. Heal. Res., vol. 4, no. 2, pp. 1–12, 2021, doi: 10.36419/avicenna.v4i2.525.
[22] I. G. M. S. Edi, “Faktor-Faktor Yang Mempengaruhi Kepatuhan Pasien Pada Pengobatan,” J. Ilm. Medicam., vol. 1, no. 1, pp. 1–8, Apr. 2020, doi: 10.36733/medicamento.v1i1.719.
[23] M. Meyrisca and R. Susanti, “Hubungan Kepatuhan Penggunaan Obat Anti TBC Dengan Keberhasilan Pengobatan Pasien TBC Di Puskesmas Sungai Betung Bengkayang,” Lumbung Farm. J. Ilmu Kefarmasian, vol. 3, no. 2, pp. 277–282, 2022.
[24] A. Amalia, H. D. Arini, S. Tinggi, F. Mahaganesha, and K. Denpasar, “Analisis Hubungan Tingkat Kepatuhan Minum Obat AntiTBC Terhadap Kualitas Hidup Pasien TBC Paru Analysis Of The Relationship Of Compliance Rate Of Antituberculosis Drug On The Quality Of Life Of Lung Tuberculosis,” vol. 1, no. 2, pp. 67–74, 2022.
[25] D. R. P. Papeo, M. Immaculata, and I. Rukmawati, “Hubungan Antara Kepatuhan Minum Obat (MMAS-8) Dan Kualitas Hidup (WHOQOL-BREF) Penderita TBC Di Puskesmas Di Kota Bandung,” Indones. J. Pharm. Educ., vol. 1, no. 2, pp. 86–97, 2021, doi: 10.37311/ijpe.v1i2.11143.
[26] A. Widiyanto, “Hubungan Kepatuhan Minum Obat Dengan Kesembuhan Pasien TBC Paru BTA Positif Di Puskesmas Delanggu Kabupaten Klaten,” Interes. J. Ilmu Kesehat., vol. 6, no. 1, pp. 7–12, 2017, doi: 10.37341/interest.v6i1.71.
Published
2023-07-31
How to Cite
Ayu Ardiyanti Fistalia, D. I., Octavia , D. R., & M.K.N, S. B. S. (2023). The Relationship between Medication Adherence and The Quality of Life of Tuberculosis Patients at the Health Center in Lamongan Regency: Hubungan Kepatuhan Minum Obat dengan Kualitas Hidup Pasien Tuberkulosis di Puskesmas Kabupaten Lamongan. Journal Pharmasci (Journal of Pharmacy and Science), 8(2), 179-185. https://doi.org/10.53342/pharmasci.v8i2.363
Section
Articles
Copyright (c) 2023 dewi indah ayu ardiyanti fistalia
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
